Clinical Trial Detail

NCT ID NCT01338987
Title Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

bone marrow cancer

acute lymphocytic leukemia

Therapies

Tacrolimus

Methotrexate

Leuprolide

Cyclophosphamide

Age Groups: child adult

Additional content available in CKB BOOST